Amphiregulin as a biomarker for monitoring lifethreatening acute graft- versus-host disease: secondary analysis of two prospective clinical trials

Haematologica. 2024 May 1;109(5):1557-1561. doi: 10.3324/haematol.2023.283215.

¹ University of Minnesota, Adult Blood and Marrow Transplant and Cell Therapy Program, Minneapolis, MN.
² University of Minnesota, Adult Blood and Marrow Transplant and Cell Therapy Program, Minneapolis, MN; Fred Hutchinson Cancer Center.
³ Biostatistics Core, Masonic Cancer Center, University of Minnesota, Minneapolis, MN.
⁴ Incyte Corporation, Wilmington, DE.
⁵ University of Minnesota, Pediatric Blood and Marrow Transplant and Cell Therapy Program, Minneapolis, MN.

No abstract available

Publication types